SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-12-198864
Filing Date
2012-05-01
Accepted
2012-05-01 09:39:54
Documents
9
Effectiveness Date
2012-05-01

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d343216ddefa14a.htm DEFA14A 58045
2 GRAPHIC g343216txs1gbgd.jpg GRAPHIC 51235
3 GRAPHIC g343216txs2gbgd.jpg GRAPHIC 13122
4 GRAPHIC g343216txs3gbgd.jpg GRAPHIC 13122
5 GRAPHIC g343216txs4gbgd.jpg GRAPHIC 37128
6 GRAPHIC g343216txs5gbgd.jpg GRAPHIC 30168
7 GRAPHIC g343216txs6gbgd.jpg GRAPHIC 47859
8 GRAPHIC g343216txs7gbgd.jpg GRAPHIC 68893
9 GRAPHIC g343216txs8gbgd.jpg GRAPHIC 13122
  Complete submission text file 0001193125-12-198864.txt   438872
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-31141 | Film No.: 12798254
SIC: 2834 Pharmaceutical Preparations